Sichuan Hebang Biotechnology Stock Retained Earnings
| 603077 Stock | 2.01 0.05 2.43% |
Sichuan Hebang Biotechnology fundamentals help investors to digest information that contributes to Sichuan Hebang's financial success or failures. It also enables traders to predict the movement of Sichuan Stock. The fundamental analysis module provides a way to measure Sichuan Hebang's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sichuan Hebang stock.
| Last Reported | Projected for Next Year | ||
| Retained Earnings | 9.6 B | 10.1 B |
Sichuan | Retained Earnings |
Sichuan Hebang Biotechnology Company Retained Earnings Analysis
Sichuan Hebang's Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Current Sichuan Hebang Retained Earnings | 9.61 B |
Most of Sichuan Hebang's fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sichuan Hebang Biotechnology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
| Competition |
Based on the latest financial disclosure, Sichuan Hebang Biotechnology has a Retained Earnings of 9.61 B. This is 49.97% lower than that of the Chemicals sector and significantly higher than that of the Materials industry. The retained earnings for all China stocks is 3.04% lower than that of the firm.
Sichuan Retained Earnings Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sichuan Hebang's direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sichuan Hebang could also be used in its relative valuation, which is a method of valuing Sichuan Hebang by comparing valuation metrics of similar companies.Sichuan Hebang is currently under evaluation in retained earnings category among its peers.
Sichuan Fundamentals
| Return On Equity | 0.0231 | ||||
| Return On Asset | 0.0139 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 18.62 B | ||||
| Shares Outstanding | 8.83 B | ||||
| Shares Owned By Insiders | 35.55 % | ||||
| Shares Owned By Institutions | 2.72 % | ||||
| Price To Book | 0.95 X | ||||
| Price To Sales | 1.92 X | ||||
| Revenue | 8.82 B | ||||
| Gross Profit | 5.55 B | ||||
| EBITDA | 1.61 B | ||||
| Net Income | 1.28 B | ||||
| Total Debt | 1.17 B | ||||
| Book Value Per Share | 2.34 X | ||||
| Cash Flow From Operations | 80.33 M | ||||
| Earnings Per Share | 0.06 X | ||||
| Target Price | 6.0 | ||||
| Number Of Employees | 7.17 K | ||||
| Beta | 0.33 | ||||
| Market Capitalization | 17.66 B | ||||
| Total Asset | 24.54 B | ||||
| Retained Earnings | 9.61 B | ||||
| Working Capital | 6.18 B | ||||
| Net Asset | 24.54 B |
About Sichuan Hebang Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sichuan Hebang Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sichuan Hebang using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sichuan Hebang Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Sichuan Stock
Sichuan Hebang financial ratios help investors to determine whether Sichuan Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sichuan with respect to the benefits of owning Sichuan Hebang security.